Directorate Change

RNS Number:4100U
Bespak PLC
20 January 2004


For Immediate Release                                         20 January 2004


                                  Bespak plc

                     Appoints new Chairman to the Board

Bespak plc (LSE: BPK), an innovator in drug delivery, is today pleased to
announce with immediate effect the appointment of John Robinson, ex-Smith &
Nephew, as the new Chairman of the Company.

Sir David Cooksey, who has served as Chairman of Bespak for the past eight years
and as a director for ten years, has stepped down from the Board today.

Sir David will be replaced by John Robinson, who from 1990 to 1997 was Chief
Executive of Smith & Nephew, the largest medical technology company in the UK.
John was subsequently Chairman of Smith & Nephew until 2000.

He is currently Chairman of George Wimpey, Chairman of Paragon Healthcare Group
and Chairman and Pro-Chancellor of the University of Hull.  Previously he has
held positions at companies that include ICI, Fisons and Railtrack Group.



Mark Throdahl, Chief Executive of Bespak, commented:

"Over the past few years Bespak has been transformed from a manufacturing to a
technology-led business.  Sir David has been instrumental in this
transformation, particularly through his emphasis on R&D investment.

"I am delighted to welcome John Robinson as Chairman and am extremely pleased
that we can attract a medical technology leader of his stature to Bespak.  He
will bring management strength and outstanding industry experience to our
Company."


For further information please call:


Bespak plc
Mark Throdahl - Chief Executive               On 20.01.04:  [phone]
                                              Thereafter: [phone]

Buchanan Communications                       [phone]
Tim Thompson/Mark Court/ Mary-Jane Johnson




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAGUUGCGUPCGBB